Galderma reports menopausal-skin treatment-sequencing research
Source publication date
Site published
An eight-month study favored Restylane Skinboosters before Sculptra. The cited clinical evidence is company-held data.
Summary
The release distinguishes menopausal skin changes from general aging.
Editorial view
Analysis: evaluate life-stage-specific skincare evidence.
Evidence and limitations
Full methods, sample size and detailed safety remain unverified. This does not establish systemic rejuvenation or longevity.